• About WordPress
    • WordPress.org
    • Documentation
    • Learn WordPress
    • Support
    • Feedback
  • Log In
  • Request Membership
Skip to content
Medxy AI Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • news
  • Page 50
Five Oral Obesity Drugs That Could Rival Eli Lilly’s Orforglipron in the Weight Loss Arena
Posted inClinical Updates Diabetes & Endocrinology news Specialties

Five Oral Obesity Drugs That Could Rival Eli Lilly’s Orforglipron in the Weight Loss Arena

Posted by By MedXY 08/17/2025
Eli Lilly's oral GLP-1 drug orforglipron marks a milestone in obesity treatment, yet competition from novel oral therapies by Novo Nordisk, Viking Therapeutics, Roche, Terns Pharmaceuticals, and Rhythm Pharmaceuticals is intensifying, promising diverse mechanisms and potential market shifts.
Read More
Running Right: The Simple, Science-Backed Path to Better Health and Longevity
Posted inFamily Medicine & Nutrition news Specialties

Running Right: The Simple, Science-Backed Path to Better Health and Longevity

Posted by By MedXY 08/17/2025
Discover how moderate, regular running boosts heart health, controls weight, improves sleep, lowers cancer risk, and extends life—without needing to run long or fast every day.
Read More
The Golden Duration of Jogging: How Much Running is Really Healthy?
Posted inFamily Medicine & Nutrition news Specialties

The Golden Duration of Jogging: How Much Running is Really Healthy?

Posted by By MedXY 08/17/2025
Discover why 10 to 30 minutes of daily jogging is optimal for health, especially for middle-aged and older adults, supported by science and expert insights.
Read More
5 Hidden Weight Gain Traps Sabotaging Your Diet — And How to Avoid Them
Posted inFamily Medicine & Nutrition news Specialties

5 Hidden Weight Gain Traps Sabotaging Your Diet — And How to Avoid Them

Posted by By MedXY 08/17/2025
Discover five common pitfalls that secretly lead to weight gain during dieting, and learn science-backed strategies for healthy, sustainable weight loss.
Read More
Managing Heart Health in Hot and Humid Environments
Posted inFamily Medicine & Nutrition Internal Medicine news Specialties

Managing Heart Health in Hot and Humid Environments

Posted by By MedXY 08/17/2025
Learn how to protect your heart health during hot, humid weather with essential tips and recognize the early signs of distress.
Read More
Debunking Weight Loss Myths: Avoid These Pitfalls for More Effective and Healthy Weight Loss
Posted inDiabetes & Endocrinology news Specialties

Debunking Weight Loss Myths: Avoid These Pitfalls for More Effective and Healthy Weight Loss

Posted by By MedXY 08/17/2025
This article explores common weight loss misconceptions, offering scientific insights and strategies for safe and sustainable fat loss.
Read More
Debunking 7 Common Weight Loss Myths: What You Need to Know for Healthy Fat Loss
Posted inDiabetes & Endocrinology news Specialties

Debunking 7 Common Weight Loss Myths: What You Need to Know for Healthy Fat Loss

Posted by By MedXY 08/17/2025
Explore seven prevalent misconceptions about weight loss—from ignoring obesity as a disease to the dangers of rapid slimming—founded on medical evidence and expert advice to guide safe and effective weight management.
Read More
Mastering the Art of Running: Scientific Guide to Safe and Effective Running
Posted inFamily Medicine & Nutrition news Specialties

Mastering the Art of Running: Scientific Guide to Safe and Effective Running

Posted by By MedXY 08/17/2025
Discover how to prepare, run, and recover like a pro with scientifically backed tips to enhance your running experience and avoid injuries.
Read More
The Rise of Healthy Running: A Scientific Approach to Fitness
Posted inFamily Medicine & Nutrition news Specialties

The Rise of Healthy Running: A Scientific Approach to Fitness

Posted by By MedXY 08/17/2025
Healthy running emphasizes sustainable practices for improved health without the competition. Learn effective strategies, common misconceptions, and expert recommendations for a balanced approach to fitness.
Read More
Valve Underexpansion in ACURATE neo2 TAVR: Implications for Clinical Outcomes and Future Directions
Posted inCardiology Clinical Updates news Specialties

Valve Underexpansion in ACURATE neo2 TAVR: Implications for Clinical Outcomes and Future Directions

Posted by By MedXY 08/17/2025
Underexpansion of the ACURATE neo2 valve during TAVR is linked to increased risk of death, stroke, and rehospitalization at one year, suggesting that achieving optimal valve expansion may improve patient outcomes.
Read More
Tirzepatide’s Role in Obesity-Related HFpEF: Influence of BMI, Central Adiposity, and Weight Loss from the SUMMIT Trial
Posted inCardiology Diabetes & Endocrinology news Specialties

Tirzepatide’s Role in Obesity-Related HFpEF: Influence of BMI, Central Adiposity, and Weight Loss from the SUMMIT Trial

Posted by By MedXY 08/17/2025
Tirzepatide reduces heart failure risk in obese HFpEF patients regardless of BMI or central adiposity, with greater benefits on exercise capacity and symptom scores associated with higher BMI and weight loss.
Read More
Long-Term Outcomes of Vagus Nerve Stimulation Paired With Upper Extremity Rehabilitation After Stroke
Posted inClinical Updates Neurology news Specialties

Long-Term Outcomes of Vagus Nerve Stimulation Paired With Upper Extremity Rehabilitation After Stroke

Posted by By MedXY 08/17/2025
This study evaluates the lasting benefits of vagus nerve stimulation combined with rehabilitation for stroke patients suffering from upper extremity impairments.
Read More
SUMMIT MAX Trial Validates Super Large Bore HiPoint System for Effective and Safe Aspiration Thrombectomy in Large Vessel Occlusion Stroke
Posted inNeurology news Specialties

SUMMIT MAX Trial Validates Super Large Bore HiPoint System for Effective and Safe Aspiration Thrombectomy in Large Vessel Occlusion Stroke

Posted by By MedXY 08/17/2025
The SUMMIT MAX randomized trial demonstrates that the super large bore HiPoint reperfusion system is noninferior to the Vecta system in reperfusion success and safety for acute ischemic stroke due to large vessel occlusion.
Read More
Impact of Prior Reperfusion Strategies on Early versus Late Direct Oral Anticoagulation in Ischemic Stroke: Insights from the ELAN Trial Subanalysis
Posted inClinical Updates Neurology news Specialties

Impact of Prior Reperfusion Strategies on Early versus Late Direct Oral Anticoagulation in Ischemic Stroke: Insights from the ELAN Trial Subanalysis

Posted by By MedXY 08/17/2025
A subanalysis of the ELAN trial shows that prior reperfusion therapy does not alter the safety or efficacy outcomes of early versus late initiation of direct oral anticoagulants in ischemic stroke patients with atrial fibrillation.
Read More
Thoracentesis in Acute Heart Failure: Insights from the TAP-IT Randomized Controlled Trial
Posted inCardiology news Specialties

Thoracentesis in Acute Heart Failure: Insights from the TAP-IT Randomized Controlled Trial

Posted by By MedXY 08/17/2025
The TAP-IT trial found that additional thoracentesis in acute heart failure patients with pleural effusion did not improve days alive out of hospital, mortality, or length of stay compared to standard therapy alone.
Read More
Aficamten: A Breakthrough Oral Therapy for Obstructive Hypertrophic Cardiomyopathy Across Symptom Severity
Posted inCardiology Clinical Updates news Specialties

Aficamten: A Breakthrough Oral Therapy for Obstructive Hypertrophic Cardiomyopathy Across Symptom Severity

Posted by By MedXY 08/17/2025
Aficamten significantly improves exercise capacity and symptoms in obstructive hypertrophic cardiomyopathy (HCM), demonstrating robust efficacy and safety in both mildly and severely symptomatic patients.
Read More
Aficamten in Obstructive Hypertrophic Cardiomyopathy: Durable 48-Week Benefits and Insights on Combination Therapy
Posted inCardiology news Specialties

Aficamten in Obstructive Hypertrophic Cardiomyopathy: Durable 48-Week Benefits and Insights on Combination Therapy

Posted by By MedXY 08/17/2025
Aficamten shows sustained obstruction relief, symptom improvement, and favorable cardiac remodeling over 48 weeks in obstructive hypertrophic cardiomyopathy, with safe discontinuation of disopyramide possible.
Read More
Unraveling Molecular Links Between Chronic Kidney Disease and Heart Failure via the Plasma Proteome
Posted inCardiology Clinical Updates Nephrology news Specialties

Unraveling Molecular Links Between Chronic Kidney Disease and Heart Failure via the Plasma Proteome

Posted by By MedXY 08/17/2025
A comprehensive proteomic analysis from the ARIC study identifies plasma proteins linking kidney dysfunction to incident heart failure, highlighting potential biomarkers and therapeutic targets for HF prevention in CKD patients.
Read More
Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection Fraction
Posted inCardiology Clinical Updates news Specialties

Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection Fraction

Posted by By MedXY 08/17/2025
This study explores the Left Atrial Coupling Index as a key predictor in heart failure patients with preserved ejection fraction.
Read More
Antiplatelet vs Anticoagulant Therapy in Embolic Stroke of Undetermined Source: Insights from a Large Multicenter Cohort Study
Posted inClinical Updates Neurology news Specialties

Antiplatelet vs Anticoagulant Therapy in Embolic Stroke of Undetermined Source: Insights from a Large Multicenter Cohort Study

Posted by By MedXY 08/17/2025
This study found no overall advantage of anticoagulation over antiplatelet therapy in ESUS patients but identified a potential benefit of anticoagulation in those with left ventricular injury.
Read More

Posts pagination

Previous page 1 … 48 49 50 51 52 … 87 Next page
  • Environmental and Social Injustices Elevate Dementia Risk in Older Adults with End-Stage Kidney Disease: Insights from a National Registry Study
  • Perinatal Antibiotic Exposure and Childhood Infection Risk: Insights from a Large Retrospective Cohort Study
  • Enhanced Glycemic Control in Type 1 Diabetes Through Systematic Intensive Therapy and Continuous Glucose Monitoring
  • Comparative Effectiveness and Safety of PD-L1 Inhibitors with Chemotherapy in Extensive-Stage Small Cell Lung Cancer: Insights from a French Nationwide Cohort Study
  • Impact of Obesogenic Environmental Factors on Long-Term Cardiovascular Disease Risk: Insights from the Dutch OBCT Index Study
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

aging Alzheimer's disease artificial intelligence atrial fibrillation blood pressure breast cancer cardiovascular disease cardiovascular health cardiovascular risk clinical trial clinical trials depression diabetes diet epidemiology exercise gut microbiota health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality multiple myeloma nutrition obesity older adults Physical Activity Pregnancy prevention prognosis public health randomized clinical trial randomized controlled trial randomized trial sexual health targeted therapy treatment type 2 diabetes weight loss wellness women's health

Your health, we care

Copyright 2025 — Medxy AI. All rights reserved.
Scroll to Top
Sign in